Jonathan Huggins - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jonathan Huggins

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Medrxiv : the Preprint Server for Health Sciences|July 23, 2024

Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 4, 2011

RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastomaKristina A Cole, Jonathan Huggins, Michael Laquaglia, et al.

Transplantation and Cellular Therapy|February 20, 2026

Musculoskeletal Adverse Events Following BCMA CAR-T Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune CorrelatesAmber Feng, Jian Wu, Taewoong Choi, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Medrxiv : the Preprint Server for Health Sciences|July 23, 2024

Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 4, 2011

RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastomaKristina A Cole, Jonathan Huggins, Michael Laquaglia, et al.

Transplantation and Cellular Therapy|February 20, 2026

Musculoskeletal Adverse Events Following BCMA CAR-T Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune CorrelatesAmber Feng, Jian Wu, Taewoong Choi, et al.

Pageof 2